View Older Stories View More Recent Stories

Mar 13, 2025 08:02AM Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
Feb 26, 2025 07:02AM Ardelyx (ARDX) Announces Tenapanor Approved in China for Hyperphosphatemia
Feb 26, 2025 07:00AM Tenapanor Approved in China for Hyperphosphatemia
Feb 25, 2025 04:15PM Ardelyx to Participate in Upcoming Investor Conferences
Feb 20, 2025 07:30AM Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 19, 2025 08:01AM Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
Jan 30, 2025 04:30PM Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025
Jan 13, 2025 08:17AM Ardelyx (ARDX) Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
Jan 13, 2025 08:03AM Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
Jan 6, 2025 08:00AM Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Nov 20, 2024 08:00AM Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Nov 8, 2024 12:34PM Ardelyx (ARDX) Responds to District Court Decision Granting Motion to Dismiss
Nov 8, 2024 12:31PM Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Nov 8, 2024 12:31PM Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Nov 5, 2024 08:00AM Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
Oct 31, 2024 04:02PM Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
Oct 28, 2024 04:05PM Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
Oct 24, 2024 04:06PM Ardelyx (ARDX) Reports Additional Data Supporting First-In-Class XPHOZAH
Oct 24, 2024 04:05PM Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
Oct 22, 2024 04:06PM Ardelyx (ARDX) Announces Launch of Gut Matters
Oct 22, 2024 04:05PM Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
Oct 21, 2024 04:05PM Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
Oct 17, 2024 08:00AM Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
Oct 15, 2024 08:00AM Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
Oct 9, 2024 08:05AM Ardelyx (ARDX) Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
Oct 9, 2024 08:05AM Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
Sep 5, 2024 08:00AM Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
Aug 8, 2024 08:01AM Ardelyx (ARDX) Appoints Eric Foster as Chief Commercial Officer
Aug 8, 2024 08:00AM Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
Aug 1, 2024 04:01PM Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
Jul 31, 2024 08:02AM Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
Jul 18, 2024 08:00AM Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
Jul 17, 2024 05:10PM Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
Jul 2, 2024 07:02AM Ardelyx (ARDX) to Not File for TDAPA
Jul 2, 2024 07:00AM To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
Jun 28, 2024 08:17AM Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
May 30, 2024 04:02PM Ardelyx, Inc. Reports Employment Inducement Grants
May 22, 2024 08:02AM Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
May 21, 2024 08:02AM Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
May 16, 2024 08:01AM Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
May 14, 2024 04:02PM Ardelyx, Inc. Reports Employment Inducement Grants
May 7, 2024 08:01AM Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 2, 2024 04:02PM Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
May 1, 2024 08:00AM Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
Apr 18, 2024 08:00AM Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Mar 28, 2024 04:05PM Ardelyx, Inc. Reports Employment Inducement Grants
Mar 25, 2024 08:00AM Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
Mar 12, 2024 04:35PM Ardelyx, Inc. Reports Employment Inducement Grants
Feb 27, 2024 08:00AM Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
Feb 22, 2024 04:01PM Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
View More Recent Stories View Older Stories